⚕ GalenOps CRO console
← 710 (USA)

710-1385

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 710 (USA) (Dr. Silva) · consented 2012-10-29
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate ATRIAL FIBRILLATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-18 (study day 113.0); relationship: NONE

mild assessed 2026-08-18

Mild ATRIOVENTRICULAR BLOCK FIRST DEGREE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-26 (study day 29.0); relationship: NONE

mild assessed 2026-08-18

Mild BLISTER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-27 (study day 60.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-18 (study day 113.0); relationship: REMOTE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-18 (study day 51.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-27 (study day 60.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate SUPRAVENTRICULAR TACHYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-12 (study day 15.0); relationship: NONE

moderate assessed 2026-08-18

Moderate SUPRAVENTRICULAR TACHYCARDIA — outcome: RECOVERED/RESOLVED; onset 2012-11-12 (study day 15.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.